arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

DYADIC INTERNATIONAL INC

DYAI
$1.01 ▲ +0.02 (+1.51%) at close
Healthcare ·Biological Products, (No Diagnostic Substances) ·USBiological Products, (No Diagnostic Substances)
10 Visible periods
25 Metrics
Peer-ranked Benchmarks
Price Chart
19
Health
Poor
Bearish
auto_awesome

Analytical Summary

DYADIC INTERNATIONAL INC faces fundamental challenges. The fundamentals warrant careful consideration of downside risks.

Market Cap
Dividend Yield
Revenue Growth -11.6%
Op. Margin -232.8%
ROIC -461.1%
FCF / Share None
Trailing P/E
Price / Book 29.7x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

10-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$3.09M
↓ -11.6%
Net Income Profit after all expenses
$-7.36M
↓ -26.8%
Operating Margin Operating profit as % of sales
-232.8%
↓ -37.9% 0th
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability
1
Financial Health
25
Cash Quality
52

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 10 years · 35 quarters